ZBIO 8-K 2026-11-05

Zenas BioPharma, Inc. (ZBIO) 8-K dated 2026-11-05 — accession 0001104659-26-123035.

Zenas BioPharma, Inc. (ZBIO) is a biotechnology company listed on US.

Zenas BioPharma, Inc. filed a 8-K on 2026-11-05. Accession 0001104659-26-123035.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.

Not investment advice. The ZBIO SEC hub lists recent forms. The stock page is the research view.